1. Exchange of E2B files undergoing testing in Denmark

   News item 02 September 2017 Pages: 1 - 1

2. Ibrutinib: ADRs that warrant temporary discontinuation

   News item 02 September 2017 Pages: 2 - 2

3. Risk of CSCR with all formulations of corticosteroids

   News item 02 September 2017 Pages: 3 - 3

4. US safeguards for use of opioids for cough/colds in children

   News item 02 September 2017 Pages: 4 - 4

5. DPP-4 inhibitors tolerable option for T2DM patients

   Review 02 September 2017 Pages: 5 - 5

6. Drug utilisation in pregnant women: effect on registries

   Epidemiology clinical study 02 September 2017 Pages: 6 - 6

7. Montelukast cessation in children with neuropsychiatric ADRs

   Clinical study 02 September 2017 Pages: 7 - 7

8. Myasthenia gravis linked with immune checkpoint inhibitors

   Clinical study 02 September 2017 Pages: 8 - 8

9. No link between use of PPIs and Alzheimer's disease

   Clinical study 02 September 2017 Pages: 9 - 9

10. PK variability of valproate in women of childbearing age

    Clinical study 02 September 2017 Pages: 10 - 10

11. The safety of medicines in the 21st century examined

    Comment 02 September 2017 Pages: 11 - 11

12. Ventricular tachyarrhythmia risk with antihistamines assessed

    Clinical study 02 September 2017 Pages: 12 - 12

13. Acenocoumarol

    Case report 02 September 2017 Pages: 13 - 13

14. Acenocoumarol

    Case report 02 September 2017 Pages: 14 - 14

15. Aconitum

    Case report 02 September 2017 Pages: 15 - 15

16. Aldesleukin/doxorubicin-liposomal/ifosfamide

    Case report 02 September 2017 Pages: 16 - 16

17. Alendronic acid

    Case report 02 September 2017 Pages: 17 - 17

18. Alendronic acid

    Case report 02 September 2017 Pages: 18 - 18

19. Allopurinol

    Case report 02 September 2017 Pages: 19 - 19

20. Alteplase/heparin

    Case report 02 September 2017 Pages: 20 - 20

21. Amoxicillin/esomeprazole/levofloxacin

    Case report 02 September 2017 Pages: 21 - 21

22. Amphotericin-B

    Case report 02 September 2017 Pages: 22 - 22

23. Amphotericin-b-liposomal

    Case report 02 September 2017 Pages: 23 - 23

24. Amphotericin-B-liposomal

    Case report 02 September 2017 Pages: 24 - 24

25. Antibacterials

    Case report 02 September 2017 Pages: 25 - 25

26. Antidepressants/benzodiazepines overdose

    Case report 02 September 2017 Pages: 26 - 26

27. Antineoplastics

    Case report 02 September 2017 Pages: 27 - 27

28. Antineoplastics

    Case report 02 September 2017 Pages: 28 - 28

29. Antineoplastics

    Case report 02 September 2017 Pages: 29 - 29

30. Antineoplastics

    Case report 02 September 2017 Pages: 30 - 30

31. Antineoplastics

    Case report 02 September 2017 Pages: 31 - 31

32. Antineoplastics

    Case report 02 September 2017 Pages: 32 - 32

33. Antineoplastics

    Case report 02 September 2017 Pages: 33 - 33

34. Antineoplastics

    Case report 02 September 2017 Pages: 34 - 34

35. Antineoplastics

    Case report 02 September 2017 Pages: 35 - 35

36. Antineoplastics

    Case report 02 September 2017 Pages: 36 - 36

37. Antineoplastics

    Case report 02 September 2017 Pages: 37 - 37

38. Antineoplastics

    Case report 02 September 2017 Pages: 38 - 38

39. Antipsychotics

    Case report 02 September 2017 Pages: 39 - 39

40. Antipsychotics

    Case report 02 September 2017 Pages: 40 - 40

41. Antiretrovirals

    Case report 02 September 2017 Pages: 41 - 41

42. Antiretrovirals

    Case report 02 September 2017 Pages: 42 - 42

43. Antivirals

    Case report 02 September 2017 Pages: 43 - 43

44. Apixaban

    Case report 02 September 2017 Pages: 44 - 44

45. Apixaban

    Case report 02 September 2017 Pages: 45 - 45

46. Artemether/efavirenz/lumefantrine interaction

    Case report 02 September 2017 Pages: 46 - 46

47. Aspirin/prasugrel

    Case report 02 September 2017 Pages: 48 - 48

48. Asunaprevir/daclatasvir

    Case report 02 September 2017 Pages: 49 - 49

49. Atenolol/propranolol

    Case report 02 September 2017 Pages: 50 - 50

50. Axitinib

    Case report 02 September 2017 Pages: 51 - 51